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Background:  Patients living further from specialty care are less likely to receive advanced medical care and procedures, including PCI. 
However, the relationship between patient distance from PCI centers and post-discharge care and outcomes following PCI are unknown.
methods:  Using data from the CART program, we identified all PCI performed in the VA from 2008-2012. We excluded patients living >300 
miles from PCI sites to exclude seasonal changes in residence, or with private insurance or non-VA primary sources of care to maximize 
capture of readmissions. Distance to PCI site was determined using the straight-line distance (SLD) between the patient’s residence 
and the PCI site. The primary exposure was quintiles of SLD from PCI site (Q1 0-9.1 mi., Q2 9.1-24.7, Q3 24.7-53.7, Q4 53.7-99.4, Q5 
99.4-300). The primary outcome was 30 day readmission (VA, fee basis) or mortality, with a secondary outcome of 1 year mortality. We 
assessed the association between quintiles of SLD from PCI site and patient outcomes, adjusting for clinical characteristics, PCI indication, 
and insurance status. We also performed sensitivity analyses of patients undergoing PCI from 2008-2010 with available Medicare 
admissions data and all patients under age 65 (excluding Medicare eligibility).
results: Among 39,637 patients undergoing PCI in the VA, median distance to PCI site was 37 mi. (IQR 12-85). Patients in higher quintiles 
of distance were more likely to be of white race, have Medicare insurance, and less likely to present with ACS. After adjustment, increasing 
distance was associated with lower risk of 30d readmission or mortality (Q2 OR 0.87 CI 0.79-0.95, Q3 OR 0.82 CI 0.74-0.90, Q4 OR 0.74 
CI 0.67-0.82, Q5 OR 0.76 CI 068-0.84 as compared to Q1), but not 1 year mortality (Q2 OR 1.12, Q3 OR 1.031, Q4 OR 1.06, Q5 OR 1.05, 
all CIs include 1). Sensitivity analyses of 2008-2010 and Medicare-excluded data had results similar to the primary analysis.
Conclusion:  In contrast to prior analyses of distance from specialty care, increasing distance from PCI site was not associated with 
adverse outcomes in the year following PCI. Additional studies are needed to identify any differences in care utilization and management 
by distance from PCI site.
